Antonella De Luca
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 28
- Colorectal Cancer Treatments and Studies 19
- Cancer Cells and Metastasis 17
- Cancer Treatment and Pharmacology 9
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 21
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 14
-
- Lung Cancer Treatments and Mutations 29
-
- Genetic factors in colorectal cancer 9
- Co-authors
- Nicola NormannoMonica R. MaielloCaterina BiancoMario MancinoLuigi StrizziAmelia D’AlessioDavid SalomonFrancesco Caponigro
- Journals
- Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Antonella De Luca
101 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 3.4k
- Cancer Research 1.4k
- Molecular Biology 3.6k
- Pulmonary and Respiratory Medicine 1.7k
- Pathology and Forensic Medicine 619
Countries citing papers authored by Antonella De Luca
This map shows the geographic impact of Antonella De Luca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella De Luca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella De Luca more than expected).
Fields of papers citing papers by Antonella De Luca
This network shows the impact of papers produced by Antonella De Luca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella De Luca. The network helps show where Antonella De Luca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonella De Luca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 27 | |
| 6 | 2015 | 41 | |
| 7 | 2011 | 60 | |
| 8 | 2011 | 37 | |
| 9 | 2011 | 4 | |
| 10 | 2009 | 23 | |
| 11 | 2009 | 14 | |
| 12 | 2009 | 56 | |
| 13 | Zoledronic acid affects the expression of VEGF in breast cancer cells and in bone marrow stromal cells through direct and indirect mechanisms | 2008 | 1 |
| 14 | 2008 | 97 | |
| 15 | 2005 | 225 | |
| 16 | 2004 | 12 | |
| 17 | 2003 | 134 | |
| 18 | 2002 | 118 | |
| 19 | 2000 | 49 | |
| 20 | 1999 | 36 |
About Antonella De Luca
Antonella De Luca is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 102 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), HER2/EGFR in Cancer Research (28 papers), Cancer Genomics and Diagnostics (21 papers), Colorectal Cancer Treatments and Studies (19 papers), Cancer Cells and Metastasis (17 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), Genetic factors in colorectal cancer (9 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (3.4k citations), Cancer Research (1.4k citations) and Molecular Biology (3.6k citations). Antonella De Luca has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Nicola Normanno, Monica R. Maiello, Caterina Bianco, Mario Mancino, Luigi Strizzi, Amelia D’Alessio, David Salomon, Francesco Caponigro, Marianna Gallo and Gianfranco De Feo. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.